SCHERING PLOUGH CORP
10-Q/A, EX-27, 2000-11-16
PHARMACEUTICAL PREPARATIONS
Previous: SCHERING PLOUGH CORP, 10-Q/A, 2000-11-16
Next: ANHEUSER BUSCH COMPANIES INC, S-8, 2000-11-16



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS FINANCIAL DATA EXTRACTED FROM SCHERING-PLOUGH
CORPORATION AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE
MONTHS ENDED SEPTEMBER 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                            2181
<SECURITIES>                                         0
<RECEIVABLES>                                     1202
<ALLOWANCES>                                         0
<INVENTORY>                                        934
<CURRENT-ASSETS>                                  5389
<PP&E>                                            4672
<DEPRECIATION>                                    1546
<TOTAL-ASSETS>                                   10227
<CURRENT-LIABILITIES>                             3454
<BONDS>                                              0
                                0
                                          0
<COMMON>                                          1015
<OTHER-SE>                                        4790
<TOTAL-LIABILITY-AND-EQUITY>                     10227
<SALES>                                           7442
<TOTAL-REVENUES>                                  7442
<CGS>                                             1414
<TOTAL-COSTS>                                     1414
<OTHER-EXPENSES>                                   975
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   2437
<INCOME-TAX>                                       585
<INCOME-CONTINUING>                               1852
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      1852
<EPS-BASIC>                                       1.26
<EPS-DILUTED>                                     1.25



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission